Lupin gets USFDA nod to market its postherpetic neuralgia drug

The company's tablets are generic version of Pfizer Inc's Neurontin tablets in the same strengths, Lupin said.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2BTUbAp
via IFTTT